25.1 C
Warsaw
Tuesday, June 30, 2026
spot_imgspot_img

Top 5 This Week

spot_img

Related Posts

Aurora And Leafio Ink Australian Medical Cannabis Deal

spot_imgspot_img
Credit: Getty Images

Leafio is the wholesale distributor of Montu Australia. MedReleaf Australia belongs to Aurora Cannabis Inc.

Leafio has a national supply chain of more than 4,000 pharmacies. Aurora said the strategic alliance will increase patient access to their products throughout Australia and support healthcare professionals by providing them with educational resources.

Nicole Le Maistre, general manager of Leafio, comments on the transaction said:

Together, Leafio, Aurora and other trusted medical partners can help more Australians access world-class products, and gain expert knowledge. The partnership is expected to bring significant benefits to Australia’s medical marijuana industry. These include enhanced product development, trusted education and better patient outcomes.

Aurora Cannabis constructed its first facility under MMPR to comply with Health Canada’s standards in Western Canada in 2013. In 2015, the company was awarded a federal license to grow and sell medical marijuana in Canada. In the year following, Aurora Cannabis sold its very first medical cannabis gram as a licensed manufacturer. Aurora acquired MedReleaf Australia in 2024. The company began operating in 2018.

Leafio, which was founded in 2023 and is headquartered at Victoria, has warehouses located in New South Wales and Queensland. According to the company, it has 1,000+ cannabis brands. Montu Australia was founded in Melbourne in 2019. Its parent company has grown revenue by more than 19,600% in the past two years.

Aurora recently released its operational and financial results for the period of the second quarter ending on September 30th 2025. According to the company, it has achieved a record-breaking net revenue in global medical cannabis with an increase of 15% over last year. The adjusted net income for the quarter ended September 30th 2025 was $7 million compared with $3.0 for the same period in 2024.

Looking ahead, our intention is to provide continued solid results for shareholders supported by an ample cash balance and a debt-free marijuana business.” said Miguel Martin is the Executive Chairman and CEO of Aurora.

Popular Articles